Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Cancer Research

ISSN:
0008-5472
0
h-index
0
Citations
6
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
01345012022202420262022: Publications 1, Citations 02024: Publications 3, Citations 02026: Publications 2, Citations 0

Publication history

013452022202420262022: Publications 12024: Publications 32026: Publications 2

h-index evolution

Cumulative h-index by year

012022202420262022: h-index 02024: h-index 02026: h-index 0

Most-cited works

  1. Abstract 3860: Drug resistance-mediating collagens (drmCOLs) are <i>themselves</i> druggable by an FDA/EMA-approved medicine to cause cancer cell arrest and apoptosis: Proof-of-concept<i>in vitro</i>20220 citations
  2. Abstract PO3-28-05: Therapeutic Plasmapheresis as a Symptomatic Treatment for Paclitaxel-Associated Peripheral Polyneuropathy20240 citations
  3. Abstract PO1-28-05: Preventive Microsurgery in Breast Cancer Treatment20240 citations
  4. Abstract PO5-07-12: Feasibility of organized population-based mass-level mammography screening (0.2 million women) –Report from LMIC-Uzbekistan20240 citations
  5. Abstract 2510: Comprehensive genomic profiling drives precision oncology and expands accessibility to targeted therapies in Uzbek populations20260 citations
  6. Abstract 3141: Integrative genomic analysis reveals pharmacogenomic determinants of chemotherapy response20260 citations